A low dose of sumatriptan provided significantly higher 2-hour pain freedom and 2-hour pain relief vs. placebo, according to phase 3 trial findings presented at PainWeek. “The efficacy of a low ...

California-based Zogenix announced a partnership with Astellas to co-promote Sumavel DosePro, a subcutaneous injection for migraine relief. Approved in July, Sumavel DosePro (sumatriptan injection) ...

Sumatriptan is an abortive medication for migraine attacks, belonging to the triptan family. From each individual review we extracted results for pain reli. Skip to navigation Skip to main content.

Zogenix developed and commercialized the first needle-free subcutaneous injection, SUMAVEL® DosePro® (sumatriptan injection) for migraine and cluster headache.

Imitrex Nasal spray is indicated for the acute treatment of migraine with or without ... The FDA is currently not reporting a shortage for the oral tablet or subcutaneous injection formulations of ...

The FDA has approved sumatriptan ... said the nasal spray is formulated using a novel excipient called Intravail to achieve blood levels similar to a 4-mg sumatriptan subcutaneous injection, ...

The VAS for paroxysmal pain was reduced from 8.3 before to 2.4 at 15 minutes after sumatriptan injection. Pain was moderately or slightly improved after sumatriptan in 20 patients (83%) and after ...

Sumavel(TM) DosePro(TM) (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System SAN DIEGO, July 16 ...

Intrathecal sumatriptan was superior to subcutaneous injection in a model of visceral pain (intraperitoneal acetic acid), conferring a marked reduction (∼ 80%) in observed pain.

The second study had patients using sumatriptan DosePro at home as the primary way of treating migraines. Ninety-eight percent of patients were able to use it correctly as migraine attacks took place.

Find patient medical information for Sumatriptan on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...

Zogenix to Present New Case Study Highlighting Successful Repositioning of Injectable Sumatriptan for Migraine With a Novel Needle-Free Delivery Technology Presentation at the 2nd Annual Drug ...